217 related articles for article (PubMed ID: 3037419)
1. Discriminative stimulus properties of chlordiazepoxide and zolpidem. Agonist and antagonist effects of CGS 9896 and ZK 91296.
Sanger DJ; Zivkovic B
Neuropharmacology; 1987 May; 26(5):499-505. PubMed ID: 3037419
[TBL] [Abstract][Full Text] [Related]
2. Further investigation of the stimulus properties of chlordiazepoxide and zolpidem. Agonism and antagonism by two novel benzodiazepines.
Sanger DJ
Psychopharmacology (Berl); 1987; 93(3):365-8. PubMed ID: 2829266
[TBL] [Abstract][Full Text] [Related]
3. Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination.
Mirza NR; Rodgers RJ; Mathiasen LS
J Pharmacol Exp Ther; 2006 Mar; 316(3):1291-9. PubMed ID: 16339395
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus properties of beta-carbolines characterized as agonists and inverse agonists at central benzodiazepine receptors.
Stephens DN; Shearman GT; Kehr W
Psychopharmacology (Berl); 1984; 83(3):233-9. PubMed ID: 6089245
[TBL] [Abstract][Full Text] [Related]
5. The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic.
Sanger DJ; Zivkovic B
Psychopharmacology (Berl); 1986; 89(3):317-22. PubMed ID: 2873608
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus properties of anxiolytic and sedative drugs: pharmacological specificity.
Sanger DJ
Psychopharmacol Ser; 1988; 4():73-84. PubMed ID: 2899319
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus properties of CGS 9896: interactions within the GABA/benzodiazepine receptor complex.
Leidenheimer NJ; Schechter MD
Pharmacol Biochem Behav; 1988 Oct; 31(2):249-54. PubMed ID: 2854261
[TBL] [Abstract][Full Text] [Related]
8. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
[TBL] [Abstract][Full Text] [Related]
9. Inverse agonist properties of the FG 7142 discriminative stimulus.
Leidenheimer NJ; Schechter MD
Pharmacol Biochem Behav; 1991 Jan; 38(1):99-104. PubMed ID: 1850137
[TBL] [Abstract][Full Text] [Related]
10. Modulation of anxiety by beta-carbolines and other benzodiazepine receptor ligands: relationship of pharmacological to biochemical measures of efficacy.
Stephens DN; Schneider HH; Kehr W; Jensen LH; Petersen E; Honore T
Brain Res Bull; 1987 Sep; 19(3):309-18. PubMed ID: 2824003
[TBL] [Abstract][Full Text] [Related]
11. Discriminative stimulus properties of CL218872 and chlordiazepoxide in the rat.
Gardner CR
Pharmacol Biochem Behav; 1989 Dec; 34(4):711-5. PubMed ID: 2576141
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem.
Vinkers CH; Olivier B; Hanania T; Min W; Schreiber R; Hopkins SC; Campbell U; Paterson N
Eur J Pharmacol; 2011 Oct; 668(1-2):190-3. PubMed ID: 21762686
[TBL] [Abstract][Full Text] [Related]
13. Differential interactions between chlordiazepoxide, pentobarbital and benzodiazepine antagonists Ro 15-1788 and CGS 8216 in a drug discrimination procedure.
De Vry J; Slangen JL
Pharmacol Biochem Behav; 1986 Apr; 24(4):999-1005. PubMed ID: 3012604
[TBL] [Abstract][Full Text] [Related]
14. Behavioral effects of nonbenzodiazepine anxiolytic drugs: a comparison of CGS 9896 and zopiclone with chlordiazepoxide.
Sanger DJ; Joly D; Zivkovic B
J Pharmacol Exp Ther; 1985 Mar; 232(3):831-7. PubMed ID: 2857789
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the actions of the benzodiazepine antagonists Ro 15-1788 and CGS 8216 using the schedule-controlled behavior of rats.
Sanger DJ
Pharmacol Biochem Behav; 1986 Sep; 25(3):537-41. PubMed ID: 3095847
[TBL] [Abstract][Full Text] [Related]
16. Effects of chlordiazepoxide training dose on the mixed agonist-antagonist properties of benzodiazepine receptor antagonist Ro 15-1788, in a drug discrimination procedure.
De Vry J; Slangen JL
Psychopharmacology (Berl); 1986; 88(2):177-83. PubMed ID: 3006110
[TBL] [Abstract][Full Text] [Related]
17. Inverse agonist properties of the THBC discriminative stimulus: asymmetrical generalization with FG 7142.
Leidenheimer NJ; Schechter MD
Pharmacol Biochem Behav; 1991 Mar; 38(3):519-25. PubMed ID: 1648746
[TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors.
Rowlett JK; Spealman RD; Lelas S; Cook JM; Yin W
Psychopharmacology (Berl); 2003 Jan; 165(3):209-15. PubMed ID: 12420154
[TBL] [Abstract][Full Text] [Related]
19. Chlordiazepoxide-induced hyperphagia in non-food-deprived rats: effects of Ro15-1788, CGS 8216 and ZK 93 426.
Cooper SJ; Moores WR
Eur J Pharmacol; 1985 May; 112(1):39-45. PubMed ID: 3926515
[TBL] [Abstract][Full Text] [Related]
20. Discriminative stimulus properties of methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM), an inverse agonist at benzodiazepine receptors.
Nielsen EB; Jepsen SA; Nielsen M; Braestrup C
Life Sci; 1985 Jan; 36(1):15-23. PubMed ID: 2981379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
